Literature DB >> 26548681

Factors Associated with Compliance of Blood Stool Test and Use of Colonoscopy in Underserved Communities of North Miami-Dade County, Florida.

Meredith Leigh Wilcox, Juan Manuel Acuña, Pura Rodriguez de la Vega, Grettel Castro, Purnima Madhivanan.   

Abstract

INTRODUCTION: Only two-thirds of U.S. adults are compliant with screening for colorectal cancer. This study identified factors of blood stool test (BST) compliance and colonoscopy use among randomly selected households in Miami-Dade County, Florida.
METHODS: This study used cross-sectional data collected 10/2009-04/2010. Analyses were restricted to 1,118 single-family homes containing a minimum of one member ≥ 50 years.
RESULTS: Half of households were compliant with BST (55%) or completed colonoscopy (55%). Factors associated with BST compliance included retirement (adjusted odds ratio[AOR]=1.57**), being uninsured (AOR=0.64**), diagnosed morbidities (AOR=1.68**), fruit/vegetable consumption (AOR=1.60**), and using alternative medicines (AOR=1.36*). Factors associated with colonoscopy included Hispanic ethnicity (AOR=0.56**), lower education (AOR=0.66*), being single (AOR=0.65*), retirement (AOR=2.01***), being uninsured (AOR=0.61**), diagnosed morbidities (AOR=2.13***), former smoking (AOR=1.94**), and fruit/vegetable consumption (AOR=1.75***)(*p<.05;**p<.01;***p<.001).
CONCLUSION: This is the first study of factors of BST and colonoscopy in Miami-Dade County. These findings provide a basis for community-based interventions aimed at increasing screening within this population.

Entities:  

Mesh:

Year:  2015        PMID: 26548681     DOI: 10.1353/hpu.2015.0114

Source DB:  PubMed          Journal:  J Health Care Poor Underserved        ISSN: 1049-2089


  1 in total

1.  Socioeconomic status and colorectal cancer screening behaviors in a vulnerable multiethnic population.

Authors:  Eduardo J Santiago-Rodríguez; Natalie A Rivadeneira; Jacqueline M Torres; Urmimala Sarkar; Robert A Hiatt
Journal:  Ethn Health       Date:  2020-10-29       Impact factor: 2.732

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.